Back
Vanguard Tax-Exempt Bond Index Fund ETF Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison
Buy
57
VTEB
Vanguard Tax-Exempt Bond Index Fund ETF
Last Price:
$50.17
Seasonality Move:
-1.64%
Sell
40
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$26.52
Seasonality Move:
-3.24%
Buy
57
Vanguard Tax-Exempt Bond Index Fund ETF (VTEB)
is a Buy
Is Vanguard Tax-Exempt Bond Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard Tax-Exempt Bond Index Fund ETF [VTEB] share price is $50.31. The Score for VTEB is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
VTEB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $26.07. The Score for AMPH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VTEB Stock Price Chart
What is Vanguard Tax-Exempt Bond Index Fund ETF's stock price today?
-
The Vanguard Tax-Exempt Bond Index Fund ETF share price today is $50.31Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTEB is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $26.07Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMPH is experiencing slight buying pressure.
VTEB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.01 | Buy |
| Relative Strength Index (14 RSI): | 51.22 | Buy |
| Chaikin Money Flow: | 4655602 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.21 - 50.41) | Sell |
| Bollinger Bands (100): | (49.21 - 50.51) | Buy |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 49.58 | Sell |
| Chaikin Money Flow: | 55695 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.62 - 27.22) | Sell |
| Bollinger Bands (100): | (23.9 - 28.88) | Sell |
VTEB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.24 | Buy |
| 20-day SMA: | 50.3 | Buy |
| 50-day SMA: | 50.37 | Sell |
| 200-day SMA: | 49.45 | Buy |
| 8-day EMA: | 11.18 | Buy |
| 20-day EMA: | 4.79 | Buy |
| 50-day EMA: | 1.97 | Buy |
| 200-day EMA: | 0.5 | Buy |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.82 | Buy |
| 20-day SMA: | 26.42 | Sell |
| 50-day SMA: | 25.49 | Buy |
| 200-day SMA: | 25.64 | Buy |
| 8-day EMA: | 26.01 | Buy |
| 20-day EMA: | 26.15 | Sell |
| 50-day EMA: | 26.06 | Buy |
| 200-day EMA: | 27.92 | Sell |
Vanguard Tax-Exempt Bond Index Fund ETF Earnings Growth & VTEB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.20 per share.
Vanguard Tax-Exempt Bond Index Fund ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||